BRIDGEWATER, NJ--(Marketwire - April 1, 2008) - Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that the divestiture of its Active Pharmaceutical Ingredients (“API”) business to 3i (LSE: III) has been completed for a purchase price of $395 million and net after-tax proceeds of approximately $365 million.
